Short answer · Medically reviewed summary · Last updated: 2026-05-08
Neurodegeneration with Brain Iron Accumulation (NBIA) is a group of rare, inherited neurological disorders characterized by the abnormal buildup of iron in the basal ganglia, a region of the brain responsible for movement. This accumulation leads to progressive motor impairment, including dystonia, parkinsonism, and cognitive decline, often significantly impacting quality of life. What causes Neurodegeneration with Brain Iron Accumulation? NBIA is primarily caused by genetic mutations that disrupt how the body metabolizes iron or handles lipids within brain cells.
What is Neurodegeneration with Brain Iron Accumulation
What is Neurodegeneration with Brain Iron Accumulation? Plain-language, medically reviewed definition plus the lived reality told by patients.
Neurodegeneration with Brain Iron Accumulation (NBIA) is a group of rare, inherited neurological disorders characterized by the abnormal buildup of iron in the basal ganglia, a region of the brain responsible for movement. This accumulation leads to progressive motor impairment, including dystonia, parkinsonism, and cognitive decline, often significantly impacting quality of life.
What causes Neurodegeneration with Brain Iron Accumulation?
NBIA is primarily caused by genetic mutations that disrupt how the body metabolizes iron or handles lipids within brain cells. This dysfunction leads to oxidative stress and cell death. While there are over 10 recognized forms of Neurodegeneration with Brain Iron Accumulation, the most common subtype is Pantothenate Kinase-Associated Neurodegeneration (PKAN), linked to mutations in the PANK2 gene.
How does Neurodegeneration with Brain Iron Accumulation affect the body?
The disease primarily impacts the central nervous system, specifically the motor pathways. Symptoms often progress over time and can include:
- Dystonia: Involuntary muscle contractions causing repetitive or twisting movements.
- Parkinsonism: Including tremors, rigidity, and slowed physical movement (bradykinesia).
- Ocular issues: Pigmentary retinopathy or loss of vision.
- Cognitive decline: Changes in executive function or speech patterns.
Who is typically affected by the condition?
Neurodegeneration with Brain Iron Accumulation is exceptionally rare, with an estimated prevalence of 1 to 3 per 1,000,000 individuals worldwide. Onset varies significantly by subtype; PKAN often presents in early childhood, while other forms like MPAN (Mitochondrial Membrane Protein-Associated Neurodegeneration) may appear in late childhood or early adulthood. There is no known gender or geographic bias for Neurodegeneration with Brain Iron Accumulation.
How is this condition different from other movement disorders?
What differentiates Neurodegeneration with Brain Iron Accumulation from other neurological conditions is the specific "eye-of-the-tiger" sign visible on MRI scans. This distinct pattern of iron deposition in the globus pallidus is a hallmark diagnostic feature that helps neurologists confirm the diagnosis when clinical symptoms are present.
Next steps
- Consult a movement disorder specialist or a neuro-geneticist to confirm your diagnosis.
- Join the Neurodegeneration with Brain Iron Accumulation community on DiseaseMaps.org to connect with 9 other members sharing their experiences.
- Inquire about clinical trials or registries that focus on iron-chelation therapies or symptomatic management.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice; always consult with a qualified healthcare professional regarding your specific health condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD): NBIA Overview.
- Orphanet: Rare Disease Database (ORPHA: 263).
- OMIM (Online Mendelian Inheritance in Man): Clinical Synopses for NBIA subtypes.
- NBIA Disorders Association: Patient support and research resources.
